Skip to content
  • Argentina
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Europe
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Perú
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Vietnam
  • France
    • +34 96 390 53 10 Request Information
    • +34 96 390 53 10 Request Information
    FranceFrance
    • France
      • Part of brands: |
        • Nous Vous Guidons
          • Fertilité
          • Prevent inherited diseases
          • Worry-free pregnancy
        • Santé Reproductive
          • Specialists
            • ALICE
            • EMMA
            • ERA
            • EndomeTRIO
            • EMBRACE
            • CGT
            • NACE
            • PGT-A
            • PGT-M
            • POC
            • SAT
          • Patients
            • ALICE
            • EMMA
            • ERA
            • EndomeTRIO
            • EMBRACE
            • CGT
            • NACE
            • PGT-A
            • PGT-M
            • SAT
            • POC
        • À Propos de Nous
          • Igenomix Recherche
          • À propos d’Igenomix
        • Webinaires
        Genomics Precision Diagnostic > Endocrinology > Hereditary Pancreatitis

        Hereditary Pancreatitis

        Pancreatitis is a condition that occurs when the pancreas becomes inflamed leading to a state of systemic inflammation. Hereditary pancreatitis is caused by repeated episodes of pancreas inflammation.
        Overview
        Indication
        Clinical Utility
        Genes & Diseases
        Methodology
        References

        Overview

        • Pancreatitis is a condition that occurs when the pancreas becomes inflamed leading to a state of systemic inflammation. Hereditary pancreatitis is caused by repeated episodes of pancreas inflammation. The pancreas produces enzymes that help digest food and it also produces insulin, a hormone that controls blood sugar levels in the body. Episodes of pancreatitis can lead to a permanent tissue damage and loss of pancreatic function.

        • Symptoms usually begin within the first two decades but can start at any time. It is due in part to an autosomal dominant gain-of-function disorder related to mutations of the cationic trypsinogen gene with an 80% penetrance. Mutations in this gene cause a premature activation of trypsinogen to trypsin. Most cases are inherited in an autosomal dominant manner or due to a de novo gene change. 

        • The Igenomix Hereditary Pancreatitis Precision Panel can be used to make a directed and accurate differential diagnosis of acute pancreatitis ultimately leading to a better management and prognosis of the disease. It provides a comprehensive analysis of the genes involved in this disease using next-generation sequencing (NGS) to fully understand the spectrum of relevant genes involved.  

        Indication

        The Igenomix Disorders of Sex Development Precision Panel is indicated for those patients with clinical suspicion of an intersex condition presenting with the following manifestations: 

        • Abdominal pain  
        • Nausea and vomiting  
        • Weight loss  
        • Diarrhea  
        • Flatulence and bloating 
        • Fat in stools  
        • Diabetes mellitus  
        • Fever  

        Clinical Utility

        The clinical utility of this panel is: 

        • The genetic and molecular confirmation for an accurate clinical diagnosis of a symptomatic patient.  
        • Early initiation of treatment with a multidisciplinary team for early preventative strategies, surgical care and pharmacologic treatment. 
        • Risk assessment of asymptomatic family members according to the mode of inheritance. 

        Genes & Diseases

        See all genes & diseases

         

        GENE 

        OMIM DISEASES 

        INHERITANCE* 

        % GENE COVERAGE (20X) 

        HGMD** 

        CASR 

        Autosomal Dominant Hypocalcemia, Hereditary Chronic Pancreatitis, Hyperparathyroidism, Autosomal Dominant Neonatal Severe Primary Hypocalcemia, Familial Hypocalciuric Hypercalcemia, Neonatal Severe Primary Hyperparathyroidism 

        AD,AR 

        100% 

        445 of 446 

        CFTR 

        Bronchiectasis, Congenital Bilateral Absence Of Vas Deferens, Cystic Fibrosis, Hereditary Chronic Pancreatitis 

        AD,AR 

        95.45% 

        1615 of 1730 

        CLDN2 

        Male Infertility, Inflammatory Bowel Disease 

        – 

        99.94% 

        NA of NA 

        CTRC 

        Hereditary Chronic Pancreatitis 

        AD 

        100% 

        46 of 46 

        PRSS1 

        Hereditary Chronic Pancreatitis 

        AD 

        100% 

        52 of 55 

        PRSS2 

        Hereditary Chronic Pancreatitis 

        AD 

        na 

        na 

        SPINK1 

        Hereditary Chronic Pancreatitis 

        AD,AR 

        100% 

        45 of 50 

        *Inheritance: AD: Autosomal Dominant; AR: Autosomal Recessive; X: X linked; XLR: X linked Recessive; Mi: Mitochondrial; Mu: Multifactorial.  

        **Number of clinically relevant mutations according to HGMD 

        Methodology

        References

        See scientific referrals

        Raphael, K. L., & Willingham, F. F. (2016). Hereditary pancreatitis: current perspectives. Clinical and experimental gastroenterology, 9, 197–207. https://doi.org/10.2147/CEG.S84358 

        Hasan, A., Moscoso, D. I., & Kastrinos, F. (2018). The Role of Genetics in Pancreatitis. Gastrointestinal endoscopy clinics of North America, 28(4), 587–603. https://doi.org/10.1016/j.giec.2018.06.001 

        Howes, N., Lerch, M., Greenhalf, W., Stocken, D., Ellis, I., & Simon, P. et al. (2004). Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clinical Gastroenterology And Hepatology, 2(3), 252-261. doi: 10.1016/s1542-3565(04)00013-8 

        Joergensen, M., Brusgaard, K., Crüger, D., Gerdes, A., & de Muckadell, O. (2010). Genetic, Epidemiological, and Clinical Aspects of Hereditary Pancreatitis: A Population-Based Cohort Study in Denmark. American Journal Of Gastroenterology, 105(8), 1876-1883. doi: 10.1038/ajg.2010.193 

        Keiles, S., & Kammesheidt, A. (2006). Identification of CFTR, PRSS1, and SPINK1 Mutations in 381 Patients With Pancreatitis. Pancreas, 33(3), 221-227. doi: 10.1097/01.mpa.0000232014.94974.75 

        Solomon, S., & Whitcomb, D. (2012). Genetics of Pancreatitis: An Update for Clinicians and Genetic Counselors. Current Gastroenterology Reports, 14(2), 112-117. doi: 10.1007/s11894-012-0240-1 

        BROCHURE

        Download

        Request Information


        • reCAPTCHA demo: Simple page

        Fertilité

        Fertilité
        Éviter les maladies génétiques

        Test prénatal non-invasif

        Pour voir le certificat d'accréditation, l'annexe technique associée et la liste des tests accrédités, cliquez sur ce lien.

        Nos services

        Nos services
        Patients
        D'envoyer les échantillons
        Manuel d'utilisateur

        À propos d’Igenomix

        À propos d’Igenomix
        Igenomix dans le monde
        Quality
        Work with us

        SUIVRE IGENOMIX

          + 96 390 53 10
        Écrivez-nous
        • Argentina
        • Brazil
        • Canada
        • Chile
        • Colombia
        • Europe
        • France
        • Germany
        • India
        • Italy
        • Japan
        • Korea
        • Mexico
        • Perú
        • Russia
        • Spain
        • Taiwan
        • The Middle East
        • Turkey
        • United Kingdom
        • United States
        • Vietnam
        France

        [2021] © Igenomix Politique de confidentialité Politique de qualité Note juridique Politique de cookiesActualités et presse 

        Demander des informations


        • reCAPTCHA demo: Simple page

        • Nous Vous Guidons
          • Fertilité
          • Prevent inherited diseases
          • Worry-free pregnancy
        • Santé Reproductive
          • Specialists
            • ALICE
            • EMMA
            • ERA
            • EndomeTRIO
            • EMBRACE
            • CGT
            • NACE
            • PGT-A
            • PGT-M
            • POC
            • SAT
          • Patients
            • ALICE
            • EMMA
            • ERA
            • EndomeTRIO
            • EMBRACE
            • CGT
            • NACE
            • PGT-A
            • PGT-M
            • SAT
            • POC
        • À Propos de Nous
          • Igenomix Recherche
          • À propos d’Igenomix
        • Webinaires
        • France
        • +34 96 390 53 10 Request Information

        We are using cookies to give you the best experience on our website.

        You can find out more about which cookies we are using or switch them off in settings.

        France
        Powered by  GDPR Cookie Compliance
        Privacy Overview

        This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

        Strictly Necessary Cookies

        Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

        If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.